Maamari, Julian; Yeung, Sai-Ching J.; Chaftari, Patrick S.
(2019-09-12)
Immune checkpoint inhibitors are a new class of anticancer drugs recently approved by the US Food and Drug Administration (FDA) for the treatment of various malignancies. Pembrolizumab is an immune checkpoint inhibitor ...